Subject(s)
Jaundice, Obstructive/etiology , Lymphoma, Non-Hodgkin/complications , Pancreatic Neoplasms/complications , Adenocarcinoma/diagnosis , Chemoradiotherapy , Diagnosis, Differential , Female , Humans , Jaundice, Obstructive/diagnostic imaging , Jaundice, Obstructive/therapy , Lymphoma, Non-Hodgkin/diagnostic imaging , Lymphoma, Non-Hodgkin/therapy , Middle Aged , Pancreatic Neoplasms/diagnostic imaging , UltrasonographyABSTRACT
Pleomorphic fibroma of the skin was described by Kamino et al 1 in 1989. It is a benign fibroblastic proliferation with cytologic atypia. This article describes a case of a myxoid variant of pleomorphic fibroma of the skin.
Subject(s)
Fibroma/pathology , Skin Neoplasms/pathology , Fibroma/surgery , Hallux , Humans , Immunohistochemistry , Male , Middle Aged , Skin Neoplasms/surgeryABSTRACT
El fibroma pleomórfico de la piel fue descrito por Kamino et al en 1989. Es una proliferación fibroblástica benigna en la que existe atipia citológica. Este artículo describe un caso de una variante mixoide del fibroma cutáneo pleomórfico
Pleomorphic fibroma of the skin was described by Kamino et al 1 in 1989. It is a benign fibroblastic proliferation with cytologic atypia. This article describes a case of a myxoid variant of pleomorphic fibroma of the skin
Subject(s)
Middle Aged , Male , Humans , Leiomyosarcoma/diagnosis , Leiomyosarcoma/therapy , Fibroma/complications , Fibroma/diagnosis , Immunohistochemistry/methods , Diagnosis, Differential , Histiocytoma, Benign Fibrous/complications , Histiocytoma, Benign Fibrous/diagnosis , Histiocytoma, Benign Fibrous/surgery , Liposarcoma/complications , Liposarcoma/diagnosis , Carcinoma/complications , Carcinoma/diagnosisABSTRACT
A case of toxic liver disease induced by cyanamide in a patient in treatment with this drug during 18 months, is presented. We reviewed the different liver cell alterations produced by a long-term treatment with cyanamide, which produces fibrosis and portal inflammation, as well as polished cells with different characteristic features. These alterations forced the establishing of close controls of patients in treatment with this type of anti-alcoholism drug, as well as the reduction of the duration of therapy, this questioning the efficacy of the treatment of chronic alcoholism with this aversive drug.
